These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. [Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide]. Täuber VU; Amin M; Fuchs P; Speck U Arzneimittelforschung; 1976; 26(7b):1492-5. PubMed ID: 1036945 [TBL] [Abstract][Full Text] [Related]
33. The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation. Ishikawa H; Mori Y; Tsurufuji S Eur J Pharmacol; 1969 Aug; 7(2):201-5. PubMed ID: 5345995 [No Abstract] [Full Text] [Related]
34. [Effects of tropical application of steroids on the skin]. Tagami H Hifuka Kiyo; 1971 Feb; 66(1):1-45. PubMed ID: 5170320 [No Abstract] [Full Text] [Related]
35. The systemic and local effects of dexamethasone, triamcinolone, 6 alpha-fluorotriamcinolone, and certain of their derivatives, compared by reference to their influence on the foreign-body granuloma, on the weight of the adrenals and thymus, and on the rate of weight gain. Desaulles PA; Samsel J Hormones; 1971; 2(4):204-15. PubMed ID: 5006661 [No Abstract] [Full Text] [Related]
36. [Pharmacodynamic and metabolic characteristics of a new dermosteroid: Formocortal]. Sala G; Castegnaro E G Ital Dermatol Minerva Dermatol; 1970 Jul; 45(7):451-62. PubMed ID: 5537424 [No Abstract] [Full Text] [Related]
37. [The influence of vehicule composition and corticosteroids sensitivity on the vasoconstrictor activity of a new topical corticosteroid, difluprednate (author's transl)]. Girard J; Sagon J; Barbier A; Tardieu JC; Lafille C J Pharm Belg; 1978; 33(6):341-50. PubMed ID: 748519 [No Abstract] [Full Text] [Related]
38. Paper-patch test for evaluating vasoconstrictive activity of corticosteroids. Falconi G; Rossi GL Arch Dermatol; 1972 Jun; 105(6):856-8. PubMed ID: 5030235 [No Abstract] [Full Text] [Related]
39. Development of glucocorticosteroids with enhanced ratio between topical and systemic effects. Thalén A; Brattsand R; Andersson PH Acta Derm Venereol Suppl (Stockh); 1989; 151():11-9; discussion 47-52. PubMed ID: 2624062 [TBL] [Abstract][Full Text] [Related]
40. [Comparative pharmacological activity of triamcinolone acetonide and of a new topical steroid: amcinonide, after percutaneous or oral administration (author's transl)]. Wepierre J; Bogaievsky Y J Pharmacol; 1980; 11(4):449-62. PubMed ID: 7206733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]